Worth reading
—
Scored from 0 of 6 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Avoiding a definitive answer
How definitive the wording is.Results for this period
Interim period (second quarter)Changes in the scope of consolidationNew USM HEALTHCARE MEDICAL DEVICES JOINT STOCK COMPANY (1 company) / Excluded Not disclosed
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Changes in the scope of consolidation | New USM HEALTHCARE MEDICAL DEVICES JOINT STOCK COMPANY (1 company) / Excluded Not disclosed |
Items this document does not state (36)
Accounting standardsConsolidated / non-consolidatedPeriod CoveredNet SalesOperating profitOrdinary incomeProfit attributable to owners of the parentNet income per shareOperating MarginEquity ratioTotal assetsNet assetsCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodFull-year earnings forecastRevision to Earnings ForecastAnnual Dividend ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogDepreciation and amortizationImpairment lossBreakdown of extraordinary income (loss)Disclosure regarding the going concern assumptionChange in accounting policyMaterial subsequent eventsAvailability of Supplementary Financial Results MaterialsAvailability of Financial Results BriefingIssued Shares at Period-EndTreasury Shares at Period-EndFactors Behind Changes in Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Improper accounting practices, primarily involving circular transactions, were identified at USM, which became a consolidated subsidiary in May 2026, during the period before its acquisition. As the investigation covers a wide scope and the possibility of additional off-balance-sheet liabilities has also come to light, the Company expects that considerable time will be required to complete the investigation, prepare the consolidated financial statements, and undergo the audit and review by the accounting firm.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.